FCNCA stock news
This page provides real-time market news, earnings updates, and company announcements related to First Citizens BancShares, Inc. (FCNCA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-03 08:50 EST

Saia Provides January and February LTL Operating Data
Finviz2026-03-03 12:33:14

Abeona Therapeutics Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
Finviz2026-03-03 12:33:14

Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors
Finviz2026-03-03 12:33:14

HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership to Enter AI-Powered Health Management Track
Finviz2026-03-03 12:33:14
Is the First Trust Large Cap Core AlphaDEX ETF (FEX) Currently a Top ETF Choice?
101 finance2026-03-03 12:24:48

Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
EXCLUSIVE: Gaxos.ai Acquires Stake In US Defense Company To Build 'Made In America' Drones
Finviz2026-03-03 12:48:45
Logistics service provider Hub Group Inc recently announced that the company needs more time to complete the restatement of its financial statements for the first, second, and third quarters of fiscal year 2025.
老虎证券2026-03-03 13:03:29

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
Finviz2026-03-03 13:03:53

Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Finviz2026-03-03 13:03:53

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Bear Pick for Today: OneSpaWorld (OSW)
101 finance2026-03-03 13:03:47

Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
Finviz2026-03-03 13:03:51

Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
Finviz2026-03-03 13:03:53

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Finviz2026-03-03 13:03:53

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52

Enphase Energy and Capital Good Fund to Expand IQ Microinverter Deployments for Small Commercial and Residential Projects in the United States
Finviz2026-03-03 13:03:53

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
Finviz2026-03-03 13:03:52

Kratos Receives $7 Million Order for Counter-UAS Systems
Finviz2026-03-03 13:03:53

Aptera Motors Completes First Vehicle off Validation Assembly Line
Finviz2026-03-03 13:03:50
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million
Finviz2026-03-03 13:06:40

Hub Group Files Form 12b-25
Finviz2026-03-03 13:06:40
Rein Therapeutics: An Original Approach to Regenerative IPF Positioned at the S-Curve Turning Point
101 finance2026-03-03 13:21:51

Birchtech Issues Shareholder Letter and Provides Corporate Update
Finviz2026-03-03 13:36:08
Is the First Trust Large Cap Core AlphaDEX ETF (FEX) Currently a Top ETF Choice?
101 finance2026-03-03 12:24:48

Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
EXCLUSIVE: Gaxos.ai Acquires Stake In US Defense Company To Build 'Made In America' Drones
Finviz2026-03-03 12:48:45
Logistics service provider Hub Group Inc recently announced that the company needs more time to complete the restatement of its financial statements for the first, second, and third quarters of fiscal year 2025.
老虎证券2026-03-03 13:03:29

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
Finviz2026-03-03 13:03:53

Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Finviz2026-03-03 13:03:53

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Bear Pick for Today: OneSpaWorld (OSW)
101 finance2026-03-03 13:03:47

Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
Finviz2026-03-03 13:03:51

Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
Finviz2026-03-03 13:03:53

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Finviz2026-03-03 13:03:53

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52

Enphase Energy and Capital Good Fund to Expand IQ Microinverter Deployments for Small Commercial and Residential Projects in the United States
Finviz2026-03-03 13:03:53

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
Finviz2026-03-03 13:03:52

Kratos Receives $7 Million Order for Counter-UAS Systems
Finviz2026-03-03 13:03:53

Aptera Motors Completes First Vehicle off Validation Assembly Line
Finviz2026-03-03 13:03:50
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million
Finviz2026-03-03 13:06:40

Hub Group Files Form 12b-25
Finviz2026-03-03 13:06:40
Rein Therapeutics: An Original Approach to Regenerative IPF Positioned at the S-Curve Turning Point
101 finance2026-03-03 13:21:51

Birchtech Issues Shareholder Letter and Provides Corporate Update
Finviz2026-03-03 13:36:08
FCNCA stock chart
FCNCA stock detailsFCNCA stock price change
On the last trading day, FCNCA stock closed at 1898.15 USD, with a price change of -5.15% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more